david bulmer
Barts and The London School of Medicine and Dentistry, Queen Mary University of London
London, United Kingdom
Associate Editor
Gastrointestinal and Hepatic Pharmacology
Barts and The London School of Medicine and Dentistry, Queen Mary University of London
London, United Kingdom
Associate Editor
Gastrointestinal and Hepatic Pharmacology
School of Medicine, Johns Hopkins University
Baltimore, United States
Associate Editor
Obstetric and Pediatric Pharmacology
North-West University
Potchefstroom, South Africa
Associate Editor
Pharmaceutical Medicine and Outcomes Research
Dr. Margarete Fischer-Bosch Institut fĂĽr Klinische Pharmakologie (IKP)
Stuttgart, Germany
Associate Editor
Pharmacogenetics and Pharmacogenomics
Weill Cornell Medicine- Qatar
Ar-Rayyan, Qatar
Associate Editor
Ethnopharmacology
University of Nebraska Medical Center
Omaha, United States
Associate Editor
Inflammation Pharmacology
National Institute of Cancerology (INCAN)
Mexico City, Mexico
Associate Editor
Pharmacogenetics and Pharmacogenomics
Texas Southern University
Houston, United States
Associate Editor
Experimental Pharmacology and Drug Discovery
School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong
Pok Fu Lam, Hong Kong, SAR China
Associate Editor
Inflammation Pharmacology
College of Korean Medicine, Kyung Hee University
Seoul, Republic of Korea
Associate Editor
Neuropharmacology
University of SĂŁo Paulo
SĂŁo Paulo, Brazil
Associate Editor
Experimental Pharmacology and Drug Discovery
The University of Queensland
Brisbane, Australia
Associate Editor
Neuropharmacology
University of Ferrara
Ferrara, Italy
Associate Editor
Respiratory Pharmacology
University of Padua
Padua, Italy
Associate Editor
ELSI in Science and Genetics
Cardiovascular Center, David Geffen School of Medicine, University of California, Los Angeles
Los Angeles, United States
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
University of Milan
Milan, Italy
Associate Editor
Experimental Pharmacology and Drug Discovery